Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies - Wikidata - awgldk - TriplyDB

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

http://www.wikidata.org/entity/Q34223150

about

Drug-Encoded Biomarkers for Monitoring Biological Therapies Real-time imaging of intestinal bacterial β-glucuronidase activity by hydrolysis of a fluorescent probe Inducible gene expression in tumors colonized by modified oncolytic vaccinia virus strains Vaccinia virus-mediated melanin production allows MR and optoacoustic deep tissue imaging and laser-induced thermotherapy of cancer.PEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses.Virotherapy of canine tumors with oncolytic vaccinia virus GLV-1h109 expressing an anti-VEGF single-chain antibody.Doxycycline Inducible Melanogenic Vaccinia Virus as Theranostic Anti-Cancer Agent.Humanized Mice with Subcutaneous Human Solid Tumors for Immune Response Analysis of Vaccinia Virus-Mediated Oncolysis.

P2860

Q28547768-06927900-8B63-46A7-8446-EFB6517EF9E4 Q33784710-7C9C227D-C98F-4115-94E7-398D7B59F49B Q34262005-F1DD8FC8-92D9-48C9-A797-23423E2D2C5F Q34327349-7D731CC2-E6E2-4392-8D15-1DD108C4D877 Q34403672-4E7F5CC8-16FF-4FFF-BB10-881D7CB28031 Q34455259-E67526A0-09D7-44E1-909B-6E52E2B446F8 Q35868856-A8889BD0-042B-4D48-AF5F-A3BFC65DCC44 Q40211555-11BF3905-A79B-40F7-B546-5E2F5835DCE3

P2860

Bacterial glucuronidase as general marker for oncolytic virotherapy or other biological therapies

http://www.wikidata.org/entity/Q34223150

description

2011 nî lūn-bûn

@nan

2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Bacterial glucuronidase as gen ...... or other biological therapies

@ast

Bacterial glucuronidase as gen ...... or other biological therapies

@en

Bacterial glucuronidase as gen ...... or other biological therapies

@nl

type

label

Bacterial glucuronidase as gen ...... or other biological therapies

@ast

Bacterial glucuronidase as gen ...... or other biological therapies

@en

Bacterial glucuronidase as gen ...... or other biological therapies

@nl

prefLabel

Bacterial glucuronidase as gen ...... or other biological therapies

@ast

Bacterial glucuronidase as gen ...... or other biological therapies

@en

Bacterial glucuronidase as gen ...... or other biological therapies

@nl

P1433

Q34223150-0C5EA3E6-96F4-47A3-8DFE-AA6F7054296D

P1476

Q34223150-3EDBFED7-E31D-48BF-B6F7-F1193CBA6849

P2093

Q34223150-1A390FCA-BF6E-4327-9EA4-5011FFE7ABA0

Q34223150-1B0B6E48-4C7D-4A6E-9B06-1BC0177AC205

Q34223150-8DC7BED8-B046-465B-B37F-E7DAE528FD19

Q34223150-C8A67193-91BF-4FA7-9918-3EE8E601E3D6

Q34223150-D0184844-415F-42DA-A88F-750B646A25CE

P2860

Q34223150-0EA90FD1-A886-4248-8605-2D4404421427

Q34223150-17ABE055-D78D-478B-941D-46D48EC34E88

Q34223150-1F59B97D-CFA7-490B-BB39-342F94ACD025

Q34223150-21118296-5848-48A3-9EA7-C48DC8689DC0

Q34223150-24882218-F69C-4322-97FA-0BF8A72B499D

Q34223150-42FF7489-D19D-4EAA-9C35-2DA15B980908

Q34223150-48E23B50-407A-439B-B7B0-BF66D2246CEA

Q34223150-4BAAE51D-E4C7-4CDC-9B23-EA7A09456BEF

Q34223150-5698F0D9-B4F1-42BE-8494-EED041CF286D

Q34223150-5BFD62B7-EA3E-40C5-A70E-D21F30D533BC

P2888

Q34223150-B9ED5DF0-3D12-45C4-B366-62EC22F47EA5

P304

Q34223150-8CA27A9C-4489-4E06-B42A-DE8D8D488FA0

P31

Q34223150-8CB4E1AB-EAD1-49AC-AE32-D28B2E613EC7

P356

Q34223150-E79500A3-78C4-428D-8800-4A11126DD1B5

P478

Q34223150-47A0F3D1-D749-4F8E-A300-8F6AA76A0710

P50

Q34223150-A3896BB1-BE7C-49D8-BE52-2B674248E40F

P577

Q34223150-3DC3328A-D551-44A0-B531-F29960D6A939

P5875

Q34223150-EC897176-8CA9-4D46-AD3E-38C5DC031DD6

P6179

Q34223150-2E6D475E-57E0-49EE-A2F1-739B4B63B80F

P698

Q34223150-7ED9596F-E2CE-40D6-8B66-8448981226E3

P921

Q34223150-1F74FC67-FDDF-49DB-8B76-20D319CF9E3C

P932

Q34223150-46FEEEB5-0C03-4CA1-A146-8AA76FF07222

P356

1479-5876-9-172

P1433

Journal of Translational Medicine

P1476

Bacterial glucuronidase as gen ...... or other biological therapies

@en

P2093

Barbara Härtl

http://www.w3.org/2001/XMLSchema#string

Ivaylo Gentschev

http://www.w3.org/2001/XMLSchema#string

Jochen Stritzker

http://www.w3.org/2001/XMLSchema#string

Julia B Sturm

http://www.w3.org/2001/XMLSchema#string

Michael Hess

http://www.w3.org/2001/XMLSchema#string

P2860

Insertion of the human sodium iodide symporter to facilitate deep tissue imaging does not alter oncolytic or replication capability of a novel vaccinia virus

GUS fusions: beta-glucuronidase as a sensitive and versatile gene fusion marker in higher plants

beta-Glucuronidase from Escherichia coli as a gene-fusion marker

Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.

Directed evolution of a lysosomal enzyme with enhanced activity at neutral pH by mammalian cell-surface display.

Enhanced tumor therapy using vaccinia virus strain GLV-1h68 in combination with a β-galactosidase-activatable prodrug seco-analog of duocarmycin SA.

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.

Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins.

Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.

Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer.

P2888

1479-5876-9-172

P304

172

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-9-172

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Aladar A Szalay

P577

2011-10-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51708783

http://www.w3.org/2001/XMLSchema#string

P6179

1049679118

http://www.w3.org/2001/XMLSchema#string

P698

21989091

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3207905

http://www.w3.org/2001/XMLSchema#string